Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis.
Alnefeesi Y, Chen-Li D, Krane E, Jawad MY, Rodrigues NB, Ceban F, Di Vincenzo JD, Meshkat S, Ho RCM, Gill H, Teopiz KM, Cao B, Lee Y, McIntyre RS, Rosenblat JD. Alnefeesi Y, et al. Among authors: di vincenzo jd. J Psychiatr Res. 2022 Jul;151:693-709. doi: 10.1016/j.jpsychires.2022.04.037. Epub 2022 May 25. J Psychiatr Res. 2022. PMID: 35688035 Review.
Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case Series.
Lipsitz O, Di Vincenzo JD, Rodrigues NB, Cha DS, Lee Y, Greenberg D, Teopiz KM, Ho RC, Cao B, Lin K, Subramaniapillai M, Flint AJ, Kratiuk K, McIntyre RS, Rosenblat JD. Lipsitz O, et al. Among authors: di vincenzo jd. Am J Geriatr Psychiatry. 2021 Sep;29(9):899-913. doi: 10.1016/j.jagp.2020.12.032. Epub 2021 Jan 9. Am J Geriatr Psychiatry. 2021. PMID: 33478865
Real-world effectiveness of repeated ketamine infusions for treatment resistant depression during the COVID-19 pandemic.
Rosenblat JD, Lipsitz O, Di Vincenzo JD, Rodrigues NB, Kratiuk K, Subramaniapillai M, Lee Y, Arekapudi AK, Abrishami A, Chau EH, Szpejda W, Wong L, Mansur RB, McIntyre RS. Rosenblat JD, et al. Among authors: di vincenzo jd. Psychiatry Res. 2021 Sep;303:114086. doi: 10.1016/j.psychres.2021.114086. Epub 2021 Jun 29. Psychiatry Res. 2021. PMID: 34246008 Free PMC article.
Onset and frequency of depression in post-COVID-19 syndrome: A systematic review.
Renaud-Charest O, Lui LMW, Eskander S, Ceban F, Ho R, Di Vincenzo JD, Rosenblat JD, Lee Y, Subramaniapillai M, McIntyre RS. Renaud-Charest O, et al. Among authors: di vincenzo jd. J Psychiatr Res. 2021 Dec;144:129-137. doi: 10.1016/j.jpsychires.2021.09.054. Epub 2021 Sep 30. J Psychiatr Res. 2021. PMID: 34619491 Free PMC article. Review.
Ketamine for psychotic depression: An overview of the glutamatergic system and ketamine's mechanisms associated with antidepressant and psychotomimetic effects.
Le TT, Di Vincenzo JD, Teopiz KM, Lee Y, Cha DS, Lui LMW, Rodrigues NB, Ho RC, Cao B, Lin K, Nasri F, Gill H, Lipsitz O, Subramaniapillai M, Mansur RB, Rosenblat JD, McIntyre RS. Le TT, et al. Among authors: di vincenzo jd. Psychiatry Res. 2021 Dec;306:114231. doi: 10.1016/j.psychres.2021.114231. Epub 2021 Oct 9. Psychiatry Res. 2021. PMID: 34798487 Review.
Pharmacogenomics of ketamine: A systematic review.
Meshkat S, Rodrigues NB, Di Vincenzo JD, Ceban F, Jaberi S, McIntyre RS, Lui LMW, Rosenblat JD. Meshkat S, et al. Among authors: di vincenzo jd. J Psychiatr Res. 2021 Nov 23;145:27-34. doi: 10.1016/j.jpsychires.2021.11.036. Online ahead of print. J Psychiatr Res. 2021. PMID: 34844049 Review.
Frequency analysis of symptomatic worsening following ketamine infusions for treatment resistant depression in a real-world sample: Results from the canadian rapid treatment center of excellence.
Di Vincenzo JD, Lipsitz O, Rodrigues NB, Jones BDM, Gill H, Lee Y, Lui LMW, Teopiz KM, Ho R, Lin K, Nasri F, McIntyre RS, Rosenblat JD. Di Vincenzo JD, et al. Psychiatry Res. 2022 Jan;307:114321. doi: 10.1016/j.psychres.2021.114321. Epub 2021 Dec 2. Psychiatry Res. 2022. PMID: 34890909
46 results